UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 3)
Dexterity Surgical, Inc.
_____________________________________________________________________________
(Name of Issuer)
Common Stock
_____________________________________________________________________________
(Title of Class of Securities)
252368105
__________________________
(CUSIP Number)
<PAGE>
13G
CUSIP No. 252368105
_____________________________________________________________________________
1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO.
Renaissance Capital Growth & Income Fund III, Inc. 75-2533518
_____________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)
(b)
_____________________________________________________________________________
3. SEC USE ONLY
_____________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Texas
_____________________________________________________________________________
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
_____________________________________________________________________________
5. SOLE VOTING POWER
2,385,000 shares
_____________________________________________________________________________
6. SHARED VOTING POWER
None
_____________________________________________________________________________
7. SOLE DISPOSITIVE POWER
2,385,000 shares
_____________________________________________________________________________
8. SHARED DISPOSITIVE POWER
None
_____________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,385,000 shares
_____________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
Not applicable
_____________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
19.33%
_____________________________________________________________________________
12. TYPE OF REPORTING PERSON
IV
_____________________________________________________________________________
ITEM 1.
(a), (b) Dexterity Surgical, Inc. ("Company")
12961 Park Central, Suite 1300
San Antonio, TX 78216
ITEM 2.
(a) Name of Person Filing
Renaissance Capital Growth & Income Fund III, Inc. ("Filer")
(b) Address of principal Business Office or, if none, Residence
8080 N. Central Expressway, Suite 210, LB 59
Dallas, TX 75206-1857
(c) Citizenship
Texas
(d) Title of Class of Securities
Common Stock
(e) CUSIP Number
75966V105
ITEM 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b),
check whether the person filing is a:
(a) ______ Broker or Dealer registered under Section 15 of the Act
(b) ______ Bank as defined in section 3(a)(6) of the Act
(c) ______ Insurance Company as defined in section 3(a)(19) of the Act
(d) X Investment Company registered under section 8 of the
______ Investment Company Act
(e) ______ Investment Adviser registered under section 203 of the
Investment Advisers Act of 1940
(f) ______ Employee Benefit Plan, Pension Fund which is subject to the
provisions of the Employee Retirement Income Security Act of
1974 or Endowment Fund; see section 240.13d-1(b)(1)(ii)(F)
(g) ______ Parent Holding Company, in accordance with section
240.13d-1(b)(ii)(G)(Note: See Item 7)
(h) ______ Group, in accordance with section 240.13d-1(b)(1)(ii)(H)
ITEM 4. Ownership.
(a) Amount Beneficially Owned:
On December 19, 1997, the Company and the Filer entered into a 9%
Convertible Debenture Loan Agreement for $1,500,000 due December
19, 2004, and convertible at $1.60 per share as of April 30, 1999.
On December 19, 1997, the Filer purchased 125,000 shares of the
Company's common stock. On August 11, 1998, the Filer purchased
500 shares at $1,000 per share of the Company's Series A Cumulative
Convertible Preferred Stock, convertible into common stock at $1.60
per share as of April 30, 1999. On November 19, 1998, the Filer
purchased 500 shares at $1,000 per share of the Company's Series B
Cumulative Convertible Preferred Stock, convertible into common
stock at $1.60 per share as of April 30, 1999. On March 27, 2000,
the $1,500,000 9% Convertible Debenture was revised to be
convertible at $1.00 per share. The Convertible Loan Agreement was
also amended to provide for the payment of interest from February
1, 2000 through January 31, 2001 in shares of Common Stock giving
the Filer 135,000 shares of the Company's Common Stock. All the
positions are convertible within sixty days. Thus the Filer owns
2,385,000 shares of the Company's common stock on a fully converted
basis. The Investment Advisor is Renaissance Capital Group, Inc.,
which is also Investment Manager for Renaissance US Growth and
Income Trust PLC. Renaissance US Growth and Income Trust PLC also
owns securities of Dexterity Surgical, Inc.
(b) Percent of Class
19.33%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
2,385,000 shares
(ii) shared power to vote or to direct the vote: None
(iii) sole power to dispose or to direct the disposition of:
2,385,000 shares
(iv) shared power to dispose or to direct the disposition of: None
ITEM 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of
more than five percent of the class of securities, check the following:
[ ]
ITEM 6. Ownership of More than Five Percent on Behalf of Another Person.
Not applicable.
ITEM 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company.
Not applicable.
ITEM 8. Identification and Classification of Members of the Group.
Not applicable.
ITEM 9. Notice of Dissolution of Group.
Not applicable.
ITEM 10. Certification.
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired in the ordinary
course of business and were not acquired for the purpose of and do not
have the effect of changing or influencing the control of the issuer of
such securities and were not acquired in connection with or as a
participant in any transaction having such purposes or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true,
complete and correct.
Date: April 10, 2000 /S/
__________________________________________________
Signature
Russell Cleveland, President & CEO
Renaissance Capital Growth & Income Fund III, Inc.
__________________________________________________
Name and Title
